Reuters-US Senate Democrats to try to pass bill protecting in vitro fertilization
By Richard Cowan WASHINGTON (Reuters) - Democrats on Wednesday will try rushing legislation through the U.S. Senate guaranteeing Americans' access to in vitro fertilization and other assisted
Reuters-Biotech company bets on GMO mosquitoes to fight dengue in Brazil as cases surge
By Leonardo Benassatto (Reuters) - British biotechnology company Oxitec is betting on a solution to Brazil's surging dengue cases, involving the release of genetically modified mosquitoes in an effort
Reuters-Exclusive-Eli Lilly could launch obesity drug in India next year, CEO says
By Rishika Sadam and Leroy Leo HYDERABAD (Reuters) -U.S. drugmaker Eli Lilly expects to launch Mounjaro, its blockbuster diabetes drug and wildly popular obesity treatment, in India as early as next
Reuters-Novavax says still faces strong headwinds, 2024 sales flat to lower
By Michael Erman (Reuters) -COVID-19 vaccine maker Novavax on Wednesday said it still faces significant financial difficulties and expects revenue this year to be flat or lower as it works to pick up
Reuters-In South Korea, world's lowest fertility rate plunges again in 2023
By Jihoon Lee and Cynthia Kim SEOUL (Reuters) -South Korea's fertility rate, already the world's lowest, continued its dramatic decline in 2023, as women concerned about their career advancement and
Reuters-South Korea to send military doctors to hospitals amid doctors' protest
By Jack Kim SEOUL (Reuters) - South Korea will send its military and community doctors to hospitals within the next few days as part of emergency measures to support the healthcare system after a mass
Reuters-Reckitt's quarterly sales disappoint after investigation into Middle East business
By Richa Naidu LONDON (Reuters) -Consumer goods group Reckitt on Wednesday missed fourth-quarter like-for-like net sales expectations as an investigation showed some employees had under-reported
Reuters-Viatris forecasts strong 2024 sales on higher demand for branded drugs
(Reuters) - Drugmaker Viatris forecast annual revenue above Wall Street estimates on Wednesday, banking on strong demand for its branded drugs such as Yupelri for lung disease and Breyna for asthma.
Reuters-Vivani shares skyrocket as implant reduces weight in mice
(Reuters) - Vivani Medical shares surged more than five-fold in early trading on Wednesday after the drug developer said its experimental under-the-skin drug implant helped reduce weight in obese mice